Search alternatives:
largest decrease » larger decrease (Expand Search), marked decrease (Expand Search)
small decrease » small increased (Expand Search)
teer decrease » mean decrease (Expand Search), greater decrease (Expand Search)
based small » based smart (Expand Search), based sample (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
_ largest » _ large (Expand Search)
largest decrease » larger decrease (Expand Search), marked decrease (Expand Search)
small decrease » small increased (Expand Search)
teer decrease » mean decrease (Expand Search), greater decrease (Expand Search)
based small » based smart (Expand Search), based sample (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
_ largest » _ large (Expand Search)
-
1
-
2
-
3
-
4
-
5
-
6
-
7
BA attenuated the decrease in the integrity and increase in the permeability of the epithelial barrier injury induced by LPS in Caco2 cell monolayers.
Published 2024“…<p>(<b>A)</b> Changes in TEER with increasing culture time on days 1–22. …”
-
8
-
9
Y-27632 collaborated with BA to attenuate the increase in the integrity and decrease in the permeability of epithelial barrier injury induced by LPS in Caco2 monolayers.
Published 2024“…<p>(<b>A)</b> Y-27632 collaborated with BA to attenuate the effect of LPS on TEER in Caco2 cells on days 1–22. …”
-
10
-
11
DataSheet1_Decreasing viscosity and increasing accessible load by replacing classical diluents with a hydrotrope in liquid–liquid extraction.docx
Published 2025“…We show that using hydrotropes as a diluent decreases the viscosity of solutions by more than a factor of ten, even under high load by extracted cations. …”
-
12
Table 1_Previous treatment decreases efficacy of pralsetinib in RET fusion-positive non-small-cell lung cancer.doc
Published 2025“…Background<p>Pralsetinib is a selective RET inhibitor. The ARROW trial revealed that RET fusion-positive non-small-cell lung cancer (NSCLC) can benefit from pralsetinib with tolerable adverse events (AEs). …”
-
13
-
14
-
15
<b>Nest mass in forest tits </b><b><i>Paridae</i></b><b> </b><b>increases with elevation and decreasing body mass, promoting reproductive success</b>
Published 2025“…We found that nest mass increased by ~ 60% along the elevational gradient, but the effect of canopy openness on nest mass was not significant, while nest mass decreased along the ranked species from the smallest <i>Periparus ater</i> to the medium-sized <i>Cyanistes caeruleus</i> and the largest <i>Parus major</i>. …”
-
16
Discovery of Novel Isoxazole-Based Small-Molecule Toll-Like Receptor 8 Antagonists
Published 2025Subjects: -
17
Discovery of Novel Isoxazole-Based Small-Molecule Toll-Like Receptor 8 Antagonists
Published 2025Subjects: -
18
Discovery of Novel Isoxazole-Based Small-Molecule Toll-Like Receptor 8 Antagonists
Published 2025Subjects: -
19
-
20